JOHNSON & JOHNSON Cash & Short-Term Investments 2006-2026 | JNJ
Beta
What is JOHNSON & JOHNSON's current cash & short-term investments?
JOHNSON & JOHNSON (JNJ) annual cash & short-term investments for 2025 was $20.10B, a 18.02% decline from 2024. JOHNSON & JOHNSON cash & short-term investments for the quarter ending March 29, 2026 was $22.05B.
What was JOHNSON & JOHNSON's cash & short-term investments in 2024?
JOHNSON & JOHNSON annual cash & short-term investments for 2024 was $24.52B, a 61.38% increase from 2023.
What was JOHNSON & JOHNSON's cash & short-term investments in 2023?
JOHNSON & JOHNSON annual cash & short-term investments for 2023 was $15.20B, a 51.93% decline from 2022.
What is JOHNSON & JOHNSON's 4-year cash & short-term investments CAGR?
JOHNSON & JOHNSON cash & short-term investments grew at a compound annual growth rate (CAGR) of 5.48% from FY2021 to FY2025, going from $25.18B to $20.10B over 4 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.8%
FY2019
$19.29B
→
FY2025
$20.10B
0607081011121314161718192122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $20.10B | -18.0% | 10-K |
| FY2024 | $24.52B | +61.4% | 10-K |
| FY2023 | $15.20B | -51.9% | 10-K |
| FY2022 | $31.61B | +25.5% | 10-K |
| FY2021 | $25.18B | +30.6% | 10-K |
| FY2019 | $19.29B | -2.0% | 10-K |
| FY2018 | $19.69B | +7.6% | 10-K |
| FY2017 | $18.30B | -52.3% | 10-K |
| FY2016 | $38.38B | +16.0% | 10-K |
| FY2014 | $33.09B | +13.3% | 10-K |
| FY2013 | $29.21B | +38.5% | 10-K |
| FY2012 | $21.09B | -23.8% | 10-K |
| FY2011 | $27.66B | +42.4% | 10-K |
| FY2010 | $19.43B | +51.7% | 10-K |
| FY2008 | $12.81B | +64.9% | 10-K |
| FY2007 | $7.77B | +90.3% | 10-K |
| FY2006 | $4.08B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →